|
|
||||||||
Ann Thorac Surg 2001;72:666-667
© 2001 The Society of Thoracic Surgeons
a Department of Cardiothoracic Surgery, Royal Brompton and Harefield NHS Trust, Sydney St, London, England SW3 6NP, United Kingdom
e-mail: n.khan@rbh.nthames.nhs.uk
To the Editor
We read with interest the paper by Wandschneider and colleagues [1] on the reduced S100ß release in off-pump operations and congratulate them on their commitment to a randomized design. However, in light of recent other publications, the design of their project may not be satisfactory to draw conclusions on the suitability of S100ß as a marker of cerebral damage during bypass operations [2, 3]. It is becoming clear that during operations, levels of S100ß in pericardial and operative field blood are dramatically high, and these high levels are
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |